Delivery Order SPE2DR25D1103-SPE2DR26FE282
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,359.97 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30 count). This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30-count) valued at $2,270.37. This firm fixed price contract, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,772.81 to AmerisourceBergen Drug Corp for Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a completion deadline of September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count), with a contract ceiling value of $3,302.35. This firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging), with an ultimate completion date of November 21, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for a brand-name hypertension medication to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $27,546.64 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Micardis HCT 80-25 mg tablets (unit dose, 30-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,093.19 to supply Micardis HCT 80-25 mg tablets (undivided 30 count) with a firm fixed price structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 5, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,534.49 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,118.82 to AmerisourceBergen Drug Corp for Micardis HCT 80-25 mg tablets (unit dose, 30-count packaging) with a firm fixed price structure. This contract, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,207.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30 count). The contract, with an ultimate completion date of December 10, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation and will be...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE282Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,407.34 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion on December 11, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999 million and extending through December 2026. This prime vendor agreement enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Micardis HCT antihypertensive medication ordered under this delivery order supports the agency's medical supply chain requirements for military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 12/9/25 |